Assertio Therapeutics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$49,459
$29,222
$26,488
$32,183
Gross Profit
35,805
18,545
18,702
20,572
EBITDA
17,798
-6,379
-3,377
-2,089
EBIT
12,168
-15,646
-12,646
-8,801
Net Income
11,445
-16,352
-13,541
-10,476
Net Change In Cash
49,459
29,222
26,488
32,183
Free Cash Flow
-4,767
19,091
-12,538
11,548
Cash
38,500
47,086
35,004
50,588
Basic Shares
7,100
6,398
6,378
6,367

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$124,961
$152,069
$156,234
$111,014
Gross Profit
85,734
125,049
137,486
95,182
EBITDA
5,146
53,170
90,170
38,781
EBIT
-20,683
24,941
56,774
9,667
Net Income
-21,581
-331,942
109,625
-1,281
Net Change In Cash
124,961
152,069
156,234
111,014
Free Cash Flow
26,408
48,976
78,324
5,470
Cash
50,588
73,441
64,941
36,810
Basic Shares
6,351
4,735
3,644
2,877

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$0.18
2025-06-30
-$0.17
2025-03-31
-$0.04